about
Microinjection of specific anti-IMPDH2 antibodies induces disassembly of cytoplasmic rods/rings that are primarily stationary and stable structuresStructure, expression and chromosomal localization of human p80-coilin geneAnti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapyReport of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-αColocalization of coilin and nucleolar proteins in Cajal body-like structures of micronucleated PtK2 cells.Inflammatory myopathies in childhood: correlation between nailfold capillaroscopy findings and clinical and laboratory data.Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: Preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2Outcomes of 847 childhood-onset systemic lupus erythematosus patients in three age groups.Comparison of laser Doppler imaging, fingertip lacticemy test, and nailfold capillaroscopy for assessment of digital microcirculation in systemic sclerosis.The contribution of 700,000 ORF sequence tags to the definition of the human transcriptome.Is autoimmune hepatitis a frequent finding among HCV patients with intense interface hepatitis?Imbalanced expression of functional surface molecules in regulatory and effector T cells in systemic lupus erythematosus.IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesionsAnti-rods/rings: a human model of drug-induced autoantibody generation.[Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial].High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statinsIdentification of human chromosome 22 transcribed sequences with ORF expressed sequence tags.25-Hydroxivitamin D Serum Concentration, Not Free and Bioavailable Vitamin D, Is Associated with Disease Activity in Systemic Lupus Erythematosus PatientsInternational consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results.Humoral autoimmune response heterogeneity in the spectrum of primary biliary cirrhosis.Biological anti-TNF drugs: immunogenicity underlying treatment failure and adverse events.Differential capacity of therapeutic drugs to induce Rods/Rings structures in vitro and in vivo and generation of anti-Rods/Rings autoantibodies.Follicular helper T cell in immunity and autoimmunityFrom autoantibody research to standardized diagnostic assays in the management of human diseases - report of the 12th Dresden Symposium on Autoantibodies.Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015.The Clinical Relevance of Anti-DFS70 Autoantibodies.IV Brazilian guidelines for autoantibodies on HEp-2 cells.Th17 cells and CD4(+) multifunctional T cells in patients with systemic lupus erythematosus.Future perspective for diagnosis in autoimmune diseases.Jones criteria and underdiagnosis of rheumatic fever.Absence of mycobacterial DNA in peripheral blood and artery specimens in patients with Takayasu arteritis.High frequency of immunodeficiency-like states in systemic lupus erythematosus: a cross-sectional study in 300 consecutive patients.Fc gamma receptor IIIb polymorphism and systemic lupus erythematosus: association with disease susceptibility and identification of a novel FCGR3B*01 variant.Abnormal phenotypic distribution of regulatory and effector T cells in octogenarian and nonagenarian women.Two major autoantigen-antibody systems of the mitotic spindle apparatus.Immunological and ultrastructural studies of the nuclear coiled body with autoimmune antibodies.Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
P50
Q22001144-2815DD34-20C0-4A11-8736-7C7EC5FAF63DQ24605102-A79142EF-D0C1-4ADC-A576-FD293D26DE15Q26766115-D3F00686-7828-4963-BDA6-E3CC4AF1FA21Q26782805-FBF00BB2-C5B6-457F-804F-F16A197753D7Q28483978-8E176D2B-AED9-4D7D-9A52-FC1576A76914Q33204964-66C3CF27-5487-45AF-9665-A23DAD8B6CC2Q33236184-8307E52B-BDB1-4CDE-B58D-3260A2503474Q33361237-C3B82A99-D9FA-4046-8C0F-EA6F9B542E70Q33438808-7EB1065F-5D7B-4EBE-8C84-5FD8E8B80884Q33653005-46E6D5AC-51E2-4F26-AD34-3D6E92DE0378Q33947020-6F4E44F6-7341-49AC-A73C-180004C503B0Q34041429-6C5C3ECD-B677-4D65-A1BD-CAB592DEB23FQ34193132-8B1424AB-DD88-40F4-9735-7BEE5FCBCCCAQ34604047-9660C56D-545C-4879-8A98-139CB428F705Q35053443-316DA874-8B57-46E3-8DCC-E94675F8EAC7Q35472514-4534BC28-3824-4CC5-A310-464F58F0A73FQ35782029-F6CD03CE-5955-4308-886E-B8134ED4BB71Q35822358-150922BA-A3D4-4887-AA76-92FBEB1884AFQ36249012-5F7B860A-EA1E-43B7-A768-14A569C9985EQ36523410-6A66B533-3AC3-4E69-AE23-A4E55AE9398AQ36963978-6E4F4F1A-DE9C-4043-8EDA-4CB70782327AQ38643965-D6D10149-3D73-48D9-9121-9E4E2AB35A19Q38738965-C238D366-50E4-4106-8A0F-F73706E7054DQ38812644-C181C864-AFF9-4A9C-8E98-69B0D7E1DB85Q38851084-EC1A7248-C2F9-4C5B-9989-04DF1996931EQ38851088-ABD92C4E-959A-49A5-9793-C0D60B4E5957Q38879029-3E8ADB46-321B-475E-BFB1-F96CEB0CEBF9Q38989952-2E1BB0C3-5B9B-4B29-A39C-21A73570B491Q39706579-FBC04F92-4C1D-4CCB-A22D-3CEA54F3D81BQ39950457-24054479-71AA-482A-898C-F1FCB273E8A0Q40456226-1BF72BB3-F3A9-488A-A01E-FF2A75116F4BQ40590983-04580EFD-EC0E-4600-B6A1-3742207D63C4Q40641312-1DFFE384-6236-43B8-8736-E4730DF2D225Q40869948-0E88C7EC-E31C-4189-9B77-97DD38908211Q40953320-F7D85BA3-49ED-4BAA-8DD4-487B245DA40AQ41141237-04BEDB8A-CD37-4D10-82C1-93CAEADDED6DQ41675900-06D8C23A-E7AE-49F1-B455-8FA6B2C607C4Q41930670-E3D1AEE7-B292-467E-90AA-64CC45A00259Q42214549-5CFA6FDF-EA17-47A8-880F-84181D7D67B1Q42226063-4B146E40-4676-49EF-AE3A-58DFA43775B7
P50
description
researcher ORCID ID = 0000-0001-8742-9931
@en
wetenschapper
@nl
name
Andrade LE
@ast
Andrade LE
@es
Andrade LE
@nl
Luis E. Andrade
@en
type
label
Andrade LE
@ast
Andrade LE
@es
Andrade LE
@nl
Luis E. Andrade
@en
altLabel
Andrade LE
@en
prefLabel
Andrade LE
@ast
Andrade LE
@es
Andrade LE
@nl
Luis E. Andrade
@en
P1153
35353964000
P31
P496
0000-0001-8742-9931